ADHD prescription startup Done pivoting to in-person care following DEA rule change

The startup is changing its business model that garnered controversy over reports it was over prescribing controlled substances.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.